San Diego-based Samumed, a small-molecule drug platform, has secured $438 million in funding. The investors were not named.
Source: Press Release
San Diego-based Samumed, a small-molecule drug platform, has secured $438 million in funding. The investors were not named.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.